Target
Integrase
Ligand
BDBM50162326
Substrate
n/a
Meas. Tech.
ChEMBL_306086 (CHEMBL833587)
IC50
>100000±n/a nM
Citation
 Deng, JLee, KWSanchez, TCui, MNeamati, NBriggs, JM Dynamic receptor-based pharmacophore model development and its application in designing novel HIV-1 integrase inhibitors. J Med Chem 48:1496-505 (2005) [PubMed]  Article 
Target
Name:
Integrase
Synonyms:
Human immunodeficiency virus type 1 integrase
Type:
PROTEIN
Mol. Mass.:
32231.48
Organism:
Human immunodeficiency virus 1
Description:
ChEMBL_90865
Residue:
288
Sequence:
FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTSTTVKAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRDPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKVKIIRDYGKQMAGDDCVASRQDED
  
Inhibitor
Name:
BDBM50162326
Synonyms:
2-Hydroxy-5-[2-(5-methoxy-1H-benzoimidazol-2-ylsulfanyl)-acetylamino]-benzoic acid | CHEMBL369650
Type:
Small organic molecule
Emp. Form.:
C17H15N3O5S
Mol. Mass.:
373.383
SMILES:
COc1ccc2nc(SCC(=O)Nc3ccc(O)c(c3)C(O)=O)[nH]c2c1
Structure:
Search PDB for entries with ligand similarity: